TITLE

Sunitinib

PUB. DATE
April 2015
SOURCE
Reactions Weekly;Apr2015, Vol. 1548 Issue 1, p248
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a case study of a patient with metastatic renal cell carcinoma, who developed nephrotic syndrome while on treatment with sunitinib.
ACCESSION #
102276465

 

Related Articles

  • Capecitabine monotherapy promising and well tolerated in metastatic renal cell cancer patients. Wenzel, C.; Locker, G. J.; Schmidinger, M. // Kidney;Jul/Aug2002, Vol. 11 Issue 4, p179 

    Deals with a study which aimed to determine therapeutic response and systemic toxicity of capecitabine in patients with advanced renal cell carcinoma for whom immunotherapy failed. Methodology used in the study; Results and conclusion.

  • Erratum to: Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma. Ramoner, Reinhold; Rahm, Andrea; Falkensammer, Claudia; Leonhartsberger, Nicolai; Thurnher, Martin // Cancer Immunology, Immunotherapy;Aug2010, Vol. 59 Issue 8, p1149 

    A correction to the article "Serum IgG Against Candida Predict Survival in Patients With Metastatic Renal Cell Carcinoma" that was published in May 13, 2010 is presented.

  • Sorafenib.  // Reactions Weekly;1/16/2016, Vol. 1584 Issue 1, p181 

    An abstract of the article "Sorafenib treatment for recurrent stage T1 bilateral renal cell carcinoma in patients with von Hippel-Lindau disease: A case report and literature review." by K.H. Choi is presented.

  • Rare splenic metastasis of renal cell carcinoma detected on 99mTc-MDP bone scan. Agrawal, Archi; Jatale, Prafulla; Purandare, Nilendu; Shah, Sneha; Rangarajan, Venkatesh // Indian Journal of Nuclear Medicine;Jan-Mar2014, Vol. 29 Issue 1, p60 

    A letter to the editor is presented related to a case study of a patient with rare splenic metastasis of renal cell carcinoma detected on 99mTc-99mTc-methylene diphosphonate (MDP) bone scan in a previous issue.

  • RHABDOID VARIANT OF CLEAR CELL RENAL CELL CARCINOMA- A CASE REPORT. Ahmed, Rabia; Hafeez Ud Din; Shoaib Naiyar Hashmi // Pakistan Armed Forces Medical Journal;Jun2015, Vol. 65 Issue 3, p432 

    The article presents a case study of a 62 years old male who was admitted to the Armed Forces Institute of Urology due to aching pain in both flanks specially on right side. Topics discussed include Rhabdoid Variant Renal Cell Carcinoma, presence of adult clear cell renal cell carcinoma with...

  • Size of localized renal cell carcinoma is important prognostic factor. Hiroš, Mustafa; Hasanbegović, Munira; Spahović, Hajrudin; Selimović, Mirsad; Sadović, Sabina // Medical Journal;Apr-Jun2015, Vol. 21 Issue 2, p118 

    Tumor size is one of the most important prognostic factors of renal cell carcinoma (RCC) and the mainstay of TNM classification in case of a localized tumor. The objective of this study was to validate the prognostic value of the tumor size and localization in the primary tumor of patients with...

  • β1,6- N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. Liu, Yidong; Liu, Haiou; Liu, Weisi; Zhang, Weijuan; An, Huimin; Xu, Jiejie // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1791 

    Purpose: β1,6- N-acetylglucosaminyltransferase V (MGAT5), which is required for the biosynthesis of β1,6GlcNAc-branched N-linked glycans attached to cell surface and secreted glycoproteins, accounts for oncogenic growth signal transduction during the development and progression of various...

  • Combining allogeneic immunotherapy with an mTOR inhibitor for advanced renal cell carcinoma. Tykodi, S. S.; Voong, L. N.; Warren, E. H. // Bone Marrow Transplantation;Aug2010, Vol. 45 Issue 8, p1360 

    A letter to the editor is presented which discusses the author's view on the effect of a combination between allogeneic immunotherapy and mammalian target of rapamycin kinase (mTOR) inhibitor to patients with renal cell carcinoma.

  • Incidental RCC Offers Better Survival. Charnow, Jody A. // Renal & Urology News;Jan2012, Vol. 11 Issue 1, p1 

    The article reports on the findings of a study of patients diagnosed with renal cell carcinoma (RCC) conducted in Iceland from 1971-2005 which show that the incidental detection rate of RCC has increased from 11.1% in 1971 through 1975 to 39.2% in 2001 through 2005.

  • Big Kidneys Increase RCC Death Risk.  // Renal & Urology News;Nov2012, Vol. 11 Issue 11, p26 

    The article presents information on the findings of a new report according to which in early stage renal cell carcinoma (RCC) patients, a larger kidney size is associated with greater risk of dying from the malignancy.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics